Two‐year effectiveness and safety of golimumab in ulcerative colitis: An IG‐IBD study

BACKGROUND: Few data exist regarding the long‐term effectiveness of golimumab in ulcerative colitis. No data have been reported on real‐world continuous clinical response. OBJECTIVE: This study aimed to describe the long‐term outcomes in a large cohort of patients on golimumab who had ulcerative col...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:United European Gastroenterol J
Κύριοι συγγραφείς: Pugliese, Daniela, Privitera, Giuseppe, Rogai, Francesca, Variola, Angela, Viola, Anna, Laterza, Lucrezia, Privitera, Antonino C., Allocca, Mariangela, Bossa, Fabrizio, Cappello, Maria, Daperno, Marco, Lorenzon, Greta, Mazzuoli, Silvia, Principi, Mariabeatrice, Sablich, Renato, Moser, Luisa, Ferronato, Antonio, Traini, Sara, Tapete, Gherardo, Bodini, Giorgia, Di Girolamo, Maria, Grossi, Laurino, Mocci, Giammarco, Ricci, Chiara, Saibeni, Simone, Festa, Stefano, Spagnuolo, Rocco, Cortelezzi, Claudio C., Mocciaro, Filippo, Rizzello, Fernando, Armuzzi, Alessandro
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: John Wiley and Sons Inc. 2021
Θέματα:
Inflammatory Bowel Disease
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8259241/
https://ncbi.nlm.nih.gov/pubmed/33203342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640620974308
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια